Metabolomics: An Emerging “Omics” Platform for Systems Biology and Its Implications for Huntington Disease Research

5Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.

Abstract

Huntington’s disease (HD) is a progressive, fatal neurodegenerative disease characterized by motor, cognitive, and psychiatric symptoms. The precise mechanisms of HD progression are poorly understood; however, it is known that there is an expansion of the trinucleotide cytosine-adenine-guanine (CAG) repeat in the Huntingtin gene. Important new strategies are of paramount importance to identify early biomarkers with predictive value for intervening in disease progression at a stage when cellular dysfunction has not progressed irreversibly. Metabolomics is the study of global metabolite profiles in a system (cell, tissue, or organism) under certain conditions and is becoming an essential tool for the systemic characterization of metabolites to provide a snapshot of the functional and pathophysiological states of an organism and support disease diagnosis and biomarker discovery. This review briefly highlights the historical progress of metabolomic methodologies, followed by a more detailed review of the use of metabolomics in HD research to enable a greater understanding of the pathogenesis, its early prediction, and finally the main technical platforms in the field of metabolomics.

Cite

CITATION STYLE

APA

Akyol, S., Ashrafi, N., Yilmaz, A., Turkoglu, O., & Graham, S. F. (2023, December 1). Metabolomics: An Emerging “Omics” Platform for Systems Biology and Its Implications for Huntington Disease Research. Metabolites. Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/metabo13121203

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free